Bed Bath & Beyond (Nasdaq: BBBY ) is expected to report Q3 earnings around Dec. 19. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Bed Bath & Beyond's revenues will grow 16.5% and EPS will grow 7.4%.
The average estimate for revenue is $2.73 billion. On the bottom line, the average EPS estimate is $1.02.
Last quarter, Bed Bath & Beyond tallied revenue of $2.59 billion. GAAP reported sales were 12% higher than the prior-year quarter's $2.31 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, EPS came in at $0.98. GAAP EPS of $0.98 for Q2 were 5.4% higher than the prior-year quarter's $0.93 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 39.8%, 130 basis points worse than the prior-year quarter. Operating margin was 14.1%, 200 basis points worse than the prior-year quarter. Net margin was 8.7%, 120 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $10.95 billion. The average EPS estimate is $4.62.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 1,098 members out of 1,317 rating the stock outperform, and 219 members rating it underperform. Among 437 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 394 give Bed Bath & Beyond a green thumbs-up, and 43 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Bed Bath & Beyond is outperform, with an average price target of $75.55.
Is Bed Bath & Beyond the right retailer for your portfolio? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average retailing powerhouse. Click here for instant access to this free report.
- Add Bed Bath & Beyond to My Watchlist.